The Silver MPN Center

The Richard T. Silver, M.D. Myeloproliferative Neoplasm Center at Weill Cornell is a state-of-the-art translational research and treatment center dedicated to finding a cure for MPNs, rare and serious blood diseases characterized by the overproduction of bone marrow.

By leveraging cutting-edge technology and techniques, the doctors and medical researchers at the Silver MPN Center at Weill Cornell are making groundbreaking discoveries aimed at advancing the treatment of MPN diseases and improving the quality of life for patients around the world.

Established with a $3.7 million grant from the Cancer Research & Treatment Fund, the Silver MPN Center is a cross-functional research and treatment facility that effectively bridges the gap between the laboratory and patient’s bedside. As a renowned organization for MPN and blood cancer research, the Silver MPN Center is led by Dr. Andrew Schafer, who is also a Professor of Medicine in Hematology-Oncology at Weill Cornell.

At the Silver MPN Center, doctors and scientists work hand-in-hand to deliver the latest medical discoveries safely to patients, giving immediate access to the latest advanced care, novel treatments and therapies. Located in New York on the Weill Cornell Cancer Center campus, the center honors Dr. Silver’s legacy and enormous contributions to the MPN community, working to find a cure for MPNs and other rare blood malignancies.